Private equity interest in orthopaedics continues even as reimbursement pressure tightens and operating costs climb. You may find that the first conversation happens well before you and your partners feel ready to sell. When your practice demonstrates consistent performance and operational stability, outside interest can arrive earlier than expected, particularly as healthcare private equity activity reached record deal values in 2025 and has remained strong into 2026.
What often gets missed in those early discussions is how dramatically a deal can reshape how your practice is governed and operated over time, especially in ways that only become clear after key decisions are already constrained.
The most significant challenges rarely appear in the headline valuation. They tend to emerge later, once you are functioning under a different set of priorities. Policymakers and physician organizations have increasingly raised concerns about how investor influence can affect professional autonomy and clinical decision-making.
Governance changes happen faster than expected
Governance is often the first area where meaningful change shows up after a transaction closes. Private equity deals frequently emphasize physician input and operational flexibility, but governance structures tend to fluctuate quickly in practice.
You may notice that decision-making authority changes in ways that are not immediately visible, particularly when approval requirements and reporting structures are described broadly rather than defined precisely. Decisions that once stayed within the practice can begin to require external sign-off, altering how quickly and independently you are able to act.
Even if you retain an ownership stake, your influence over how the practice operates can narrow over time. Strategic direction often becomes shared or redirected, which makes it important for you to understand how authority will function once the transaction is complete rather than relying on early assurances. Reporting on consolidation in orthopaedics has highlighted how these changes can limit physician control even when clinical independence is emphasized in principle.
Ethical analyses have also noted that the financial priorities driving private equity ownership can create tension with traditional clinical values. That tension often becomes more visible as business objectives begin to form operational decisions.
Productivity benchmarks are not suggestions
Productivity expectations tend to feel very different after an acquisition. After closing, targets are often framed as performance goals, but you are likely to experience them as enforceable expectations.
Your activity levels and output may be tracked more closely once new reporting systems are in place. Deviations rarely go unnoticed. Over time, these benchmarks can affect scheduling, case mix, and workload in ways that extend beyond compensation alone.
If your current practice patterns already align with these expectations, the transition may feel manageable. If they do not, you may feel pressure that affects how you work day to day and how your performance is evaluated over time. Commentary on physician engagement with private equity has underscored how these expectations can influence professional satisfaction and perceived autonomy.
Exit pressure influences daily operations
Exit planning influences operations earlier than many physicians expect. Private equity firms operate on defined investment timelines, and your transaction is almost certainly structured with an eventual transition in mind.
That reality determines how decisions are made inside your practice, even when it is not openly discussed. Industry analyses from 2025 and early 2026 describe investor strategies that emphasize positioning for future exits alongside operational performance.
You may begin to notice that operational choices increasingly reflect preparation for a future sale rather than long-term internal priorities. Over time, this can turn focus toward financial presentation and short-term performance indicators, even when those priorities differ from how your practice previously defined success.
In Part 2, Orthopaedics 411 will focus on how you can evaluate these issues before you commit to a deal.
Sources
Global Healthcare Private Equity Report 2026
Physician Engagement With Private Equity Firms
Private equity’s impact on orthopedics
State momentum grows to curb corporate influence in health care
